CORRECTION: InspireMD, Inc. Common Stock Q3 EPS $(0.53) Beats $(0.82) Estimate, Sales $1.07M Miss $1.20M Estimate
InspireMD, Inc. Common Stock (AMEX:NSPR) reported quarterly losses of $(0.53) per share which beat the analyst consensus estimate of $(0.82) by 35.37 percent. This is a 783.33 percent decrease over losses of $(0.06) per
InspireMD, Inc. Common Stock Q3 EPS $(0.96) Misses $(0.82) Estimate, Sales $1.07M Miss $1.20M Estimate
InspireMD, Inc. Common Stock (AMEX:NSPR) reported quarterly losses of $(0.96) per share which missed the analyst consensus estimate of $(0.82) by 17.07 percent. This is a 1500 percent decrease over losses of $(0.06) per
Earnings Scheduled For November 9, 2021
Companies Reporting Before The Bell
• Imara (NASDAQ:IMRA) is projected to report earnings for its third quarter.
• KT (NYSE:KT) is projected to report earnings for its third quarter.
50 Biggest Movers From Yesterday
Gainers
Jasper Therapeutics, Inc. (NASDAQ: JSPR) shares surged 105.1% to close at $14.79 on Wednesday after Oppenheimer initiated coverage on the stock with an Outperform rating and a $21 price target.
39 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Jasper Therapeutics, Inc. (NASDAQ: JSPR) shares jumped 113% to $15.36 after Oppenheimer initiated coverage on the stock with an Outperform rating and a $21 price target.
Mid-Morning Market Update: Markets Mixed; JPMorgan Posts Upbeat Earnings
Following the market opening Wednesday, the Dow traded down 0.36% to 34,254.62 while the NASDAQ rose 0.27% to 14,505.47. The S&P also fell, dropping 0.07% to 4,347.49.
InspireMD Reports Received Reimbursement Approval For CGuard Embolic Prevention System From French National Authority For Health
InspireMD, Inc. (NASDAQ:NSPR), a global developer of the CGuard™ Embolic Prevention Stent System (EPS) device for the treatment of Carotid Artery Disease (CAD) and stroke prevention, today announced that its CGuard
InspireMD Granted Canadian Patent Titled ‘INTRAVASCULAR ANEURYSM TREATMENT DEVICE AND METHODS’
https://www.ic.gc.ca/opic-cipo/cpd/eng/patent/3013758/summary.html
60 Biggest Movers From Friday
Gainers
Vinco Ventures, Inc. (NASDAQ: BBIG) shares rose 80.9% to close at $5.30 on Friday. The company recently reported a Q2 loss of $5.13 per share.